On January 2, 2024, Bioleaders Corporation closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,275 KRW | -1.73% | -13.83% | +6.81% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
6,720 KRW | -0.88% | -2.33% | 198M | ||
2,275 KRW | -1.73% | -13.83% | 63.78M | ||
1st Jan change | Capi. | |
---|---|---|
+6.81% | 63.78M | |
+29.98% | 684B | |
+30.34% | 568B | |
-3.52% | 361B | |
+18.59% | 329B | |
+4.07% | 284B | |
+16.21% | 240B | |
+9.66% | 208B | |
-6.83% | 200B | |
+7.09% | 166B |
- Stock Market
- Equities
- A142760 Stock
- News MOA Life Plus Co. Ltd.
- Bioleaders Corporation announced that it has received KRW 2 billion in funding from Kwang Dong Pharmaceutical Co., Ltd.